476
Participants
Start Date
September 29, 2020
Primary Completion Date
January 10, 2022
Study Completion Date
August 8, 2022
HSK7653 10 mg Q2W
HSK7653 5 mg (2 tablets) and placebo 25 mg (1 tablet), Q2W, oral, week 1 to week 24; HSK7653 25 mg (1 tablet), Q2W, oral, week 25 to week 52.
HSK7653 25 mg Q2W
HSK7653 25 mg (1 tablet) and placebo 5 mg (2 tablets), Q2W, oral, week 1 to week 24; HSK7653 25 mg (1 tablet), Q2W, oral, week 25 to week 52.
Placebo
Placebo 25 mg (1 tablet) and placebo 5 mg (2 tablets), Q2W, oral, week 1 to week 24; HSK7653 25 mg (1 tablet), Q2W, oral, week 25 to week 52.
Peking University People's Hospital, Beijing
Zhujiang Hospital of Southern Medical University, Zhujiang
Sichuan Haisco Pharmaceutical Group Co., Ltd
INDUSTRY